Average obligated amount per year since period start.
Portion of total contract value already obligated.
Share of total value represented by subawards.
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL TO EVALUATE THE ANTIVIRAL ACTIVITY, SAFETY, AND PHARMACOKINETICS OF NOVARTIS EYU688 AGAINST DENGUE VIRUS 2 INFECTION IN A CONTROLLED HUMAN INFECTION MODEL IN HEALTHY ADULT PARTICIPANTS
Task order obligations
Estimated months remaining until end of performance.
Period of performance
96% of period elapsed
Awarding Agency
NINATIONAL INSTITUTES OF HEALTH
Code: 7529
Funding Agency
NINATIONAL INSTITUTES OF HEALTH
Code: 7529
Loading contract activity data...
Modification ID | Description | Action Date | Obligated Amount | Action Type |
|---|---|---|---|---|
Subaward # | Subawardee | Description | Amount | Action Date |
|---|---|---|---|---|